{"id":"W4386024134","doi":"10.1097/01.hs9.0000967716.49281.3f","title":"S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Bendamustine; Hazard ratio; Rituximab; Gastroenterology; Confidence interval; Neutropenia; Minimal residual disease; Chronic lymphocytic leukemia; Surgery; Oncology; Leukemia; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002905279,0.0006442902,0.001877225,0.0004321066,0.000495002,0.001016229,0.0007749655,0.000948488,0.001973331],"category_scores_gemma":[0.001763977,0.0004044354,0.002404877,0.0008262328,0.0004656188,0.0005848394,0.0006649994,0.001518246,0.0006191977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001091208,"about_ca_system_score_gemma":0.001082702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002133939,"about_ca_topic_score_gemma":0.006923514,"domain_scores_codex":[0.9987914,0.0005686966,0.00009725496,0.0002168536,0.0001527755,0.0001730044],"domain_scores_gemma":[0.9983124,0.000290716,0.0004780191,0.0002733567,0.0002258319,0.0004196603],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5158298,0.007465844,0.3310331,0.002213868,0.01756619,0.0008255424,0.0008776567,0.00201987,0.02424172,0.000432102,0.02040784,0.0770865],"study_design_scores_gemma":[0.1070117,0.07972778,0.7732438,0.0002498504,0.01386022,0.001322814,0.000312558,0.001217536,0.003804513,0.0004003477,0.01876032,0.00008857761],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98344,0.002419289,0.0003246306,0.0002898131,0.0000786559,0.0007186548,0.01082095,0.00005171931,0.00185635],"genre_scores_gemma":[0.9545439,0.0008460092,0.0008201906,0.0009988965,0.00018168,0.00122037,0.0398044,0.00003481363,0.001549712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002905279,"threshold_uncertainty_score":0.01536477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02021042823609262,"score_gpt":0.2684018237487544,"score_spread":0.2481913955126618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}